Stocks in Motion: Axon Dips, Cracker Barrel Pops

A mixed bag for investors: Axon Enterprise stock fell in February, while Cracker Barrel and Zscaler saw positive movement after earnings reports. Plus, analyst updates on ATSG, Humacyte, and Aptose Biosciences.

Stocks in Motion: Axon Dips, Cracker Barrel Pops

The stock market is a constantly shifting landscape, with fortunes made and lost on a daily basis. This week, we're taking a look at some companies making headlines, from analyst ratings to surprising earnings rebounds.

Axon's February Fall

Shares of Axon Enterprise (NASDAQ: AXON), known for its tasers and body cameras used by law enforcement, experienced a 19% drop in February. The sell-off was triggered by concerns that the company's impressive streak of quarterly earnings beats might be coming to an end. While Axon did, in fact, beat earnings expectations, the stock failed to recover. Axon has enjoyed significant growth, increasing over 550% in the past five years.

Axon Enterprise body camera being worn by a police officer on patrol

Despite the setback, Axon remains a key player in providing technology solutions for law enforcement, offering not only hardware but also software systems. The company has a proven track record of expanding its customer base and introducing new products.

Cracker Barrel's Comeback

After a long period of decline, dating back to early 2021, Cracker Barrel (NASDAQ: CBRL) is finally seeing a rebound. The restaurant chain's stock jumped after the release of its fiscal 2025 second-quarter results and updated guidance. While revenue only increased modestly, and net income actually dropped, the results exceeded the low expectations of investors.

Management's decision to raise the low end of its revenue guidance for the full year suggests that sales trends are stabilizing, which has boosted investor confidence. "Sometimes, investors have such low expectations for a business that anything positive can send its shares soaring," the report stated.

Exterior of a Cracker Barrel restaurant with its iconic sign

Zscaler Surges on Strong Earnings

Zscaler (NASDAQ: ZS) is another company enjoying positive momentum, with its stock price up 7% following the release of its recent earnings report. The company's second-quarter results for fiscal year 2025, which ended January 31, exceeded market expectations for both sales and earnings.

The company reported adjusted earnings per share (EPS) of $0.78 on sales of $647.9 million, surpassing analyst estimates of $0.69 EPS on sales of $635.45 million. This strong performance has instilled confidence in investors, driving up the stock price.

Analyst Ratings Roundup

In other news, several companies have received updated analyst ratings. StockNews.com initiated coverage on Air Transport Services Group (NASDAQ:ATSG) with a "hold" rating. Meanwhile, Humacyte, Inc. (NASDAQ:HUMA) received an average "Buy" rating from eight analysts, according to MarketBeat.com.

A stylized stock ticker display showing various company symbols and stock prices

However, StockNews.com also initiated coverage on Aptose Biosciences (NASDAQ:APTO) with a "sell" rating, contrasting with other analysts, such as HC Wainwright, who maintain a "buy" rating. These varying opinions highlight the complexities of the stock market and the importance of conducting thorough research before making investment decisions.

As always, remember that past performance is not indicative of future results, and investment decisions should be made based on your own risk tolerance and financial situation.

Share this article: